Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5
Closed -$647 1253
2025
Q2
$647 Hold
5
﹤0.01% 1114
2025
Q1
$598 Sell
5
-149
-97% -$18.5K ﹤0.01% 1054
2024
Q4
$17.9K Hold
154
﹤0.01% 679
2024
Q3
$20.8K Buy
154
+150
+3,750% +$20.1K ﹤0.01% 681
2024
Q2
$543 Sell
4
-500
-99% -$68K ﹤0.01% 1137
2024
Q1
$66K Hold
504
﹤0.01% 407
2023
Q4
$57K Hold
504
﹤0.01% 415
2023
Q3
$46K Hold
504
﹤0.01% 441
2023
Q2
$56K Hold
504
﹤0.01% 426
2023
Q1
$52K Buy
504
+500
+12,500% +$52.2K ﹤0.01% 426
2022
Q4
$0 Buy
+4
New +$419 ﹤0.01% 1141

Other funds holding XYL

Asset Dedication LLC's XYL Position: Q3 2025 in Review

Asset Dedication LLC sold out of Xylem (XYL) in Q3 2025, closing a stake of 5 shares — an estimated $647 sold.

Asset Dedication LLC first reported a position in XYL in Q4 2022 and held it in 11 quarters. The position peaked at $66K in Q1 2024. 1,085 funds tracked by Wall St. Rank hold XYL as of Q3 2025.

  • Asset Dedication LLC reported no remaining Xylem position as of Q3 2025 after selling out during the quarter.
  • Asset Dedication LLC sold 5 Xylem shares in Q3 2025, an estimated $647.
  • Asset Dedication LLC first reported a position in Xylem in Q4 2022 and held it in 11 quarters.
  • Asset Dedication LLC's Xylem position peaked at $66K in Q1 2024.
  • 1,085 funds tracked by Wall St. Rank held Xylem as of Q3 2025.

Based on Asset Dedication LLC's 13F filing for Q3 2025, filed 20 Nov 2025.